Alpha Crest Capital Management LLC Global Blood Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$22.3 - $37.39 $223,468 - $374,685	10,021 New	10,021 $320,000
Q1 2022 May 12, 2022	SELL	$25.68 - $35.59 $234,484 - $324,972	-9,131 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$24.9 - $40.26 $197,058 - $318,617	-7,914 Reduced 46.43%	9,131 $267,000
Q3 2021 Nov 10, 2021	SELL	$25.48 - $37.34 $202,897 - $297,338	-7,963 Reduced 31.84%	17,045 $434,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $43.42 $811,759 - $1.09 Million	25,008 New	25,008 $876,000
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $232,144 - $327,756	-4,400 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$48.73 - $81.82 $151,063 - $253,641	-3,100 Reduced 41.33%	4,400 $278,000
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $312,900 - $654,000	7,500 New	7,500 $383,000
Q4 2019 Feb 12, 2020	SELL	$45.7 - $81.86 $260,490 - $466,602	-5,700 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $258,495 - $330,087	5,700 New	5,700 $277,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.